Current perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patient.
Liebman
Howard A
HA
Keck School of Medicine, University of Southern California, Los Angeles 90033, USA. liebman@hsc.usc.edu
D000925:Anticoagulants / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000592:standards*; D012307:Risk Factors; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants